Holen Sie sich die Stockscreener-App
16.61
2.52%
-0.43
Keros Therapeutics Inc Aktie (KROS) Neueste Nachrichten
Why Keros Therapeutics Inc. stock could see breakout soonEarnings Risk Summary & Fast Moving Stock Trade Plans - mfd.ru
Keros Therapeutics: Key Catalysts and Financial Runway in Focus - AD HOC NEWS
Price-Driven Insight from (KROS) for Rule-Based Strategy - Stock Traders Daily
Y Intercept Hong Kong Ltd Lowers Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics, Inc. $KROS Shares Sold by Federated Hermes Inc. - MarketBeat
Big Picture: What is SIDUs revenue forecastGap Up & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Risk Report: What is the next catalyst for Keros Therapeutics IncDividend Hike & High Accuracy Trade Alerts - baoquankhu1.vn
Tech Rally: Is CleanCore Solutions Incs ROE strong enough2025 Stock Rankings & Risk Managed Trade Strategies - baoquankhu1.vn
Aug Opening: Will HUB Cyber Security Ltd. Equity Warrant outperform during market ralliesJuly 2025 WrapUp & Target Return Focused Stock Picks - baoquankhu1.vn
Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside? - Nasdaq
Portfolio Shifts: Can NECB benefit from deglobalizationJuly 2025 Reactions & Community Driven Trade Alerts - baoquankhu1.vn
Market Wrap: What is the next catalyst for Keros Therapeutics IncAnalyst Downgrade & Capital Efficiency Focused Ideas - baoquankhu1.vn
Is KROS' KER-065 the Next Breakthrough in DMD Space? - The Globe and Mail
(KROS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
MRKR stock up nearly 114% in 3 months: Here's what you need to know - MSN
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - MSN
Fund Flows: Does Keros Therapeutics Inc stock reflect fundamentalsWeekly Profit Report & Smart Investment Allocation Tips - baoquankhu1.vn
Is Keros Therapeutics Inc. backed by strong institutional buyingQuarterly Trade Summary & AI Driven Price Predictions - mfd.ru
JANX Enters Global Oncology Collaboration With BMY, Stock Rises - Nasdaq
Keros Therapeutics, Inc. (KROS) Investor Outlook: Exploring a Promising 20.76% Potential Upside - DirectorsTalk Interviews
Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know - Finviz
Will KROS Stock's Restructuring Efforts Reap Rewards for Investors? - sharewise.com
Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia - Finviz
KROS Stock Surges 85.6% in a Year: More Upside Potential in 2026? - sharewise.com
CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why - Finviz
(KROS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA - Finviz
Downgrade Watch: What’s the RSI of Keros Therapeutics Inc. stock2025 Performance Recap & Long-Term Safe Investment Plans - baoquankhu1.vn
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results - Finviz
Aug Technicals: Is Keros Therapeutics Inc likely to announce a buybackJuly 2025 Reactions & Entry Point Confirmation Signals - baoquankhu1.vn
History Review: What are Keros Therapeutics Incs technical support levelsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock Rises - Zacks Investment Research
MACD Signal: Whats the fair value of Keros Therapeutics Inc stock2025 Key Highlights & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced - Finviz
Keros Therapeutics, Inc. (KROS) Stock Analysis: Strong Revenue Growth and a 26% Potential Upside - DirectorsTalk Interviews
Will Keros Therapeutics Inc. stock outperform value stocks2025 Macro Impact & Weekly Breakout Opportunity Watchlist - Улправда
How rising interest rates impact Keros Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - Улправда
What analysts say about Keros Therapeutics Inc stockSector Rotation Strategies & Real-Life Case Studies You Can Follow - earlytimes.in
Bank of America Securities Keeps Their Hold Rating on Keros Therapeutics (KROS) - The Globe and Mail
Keros Therapeutics (NASDAQ:KROS) Trading Down 3.3% on Analyst Downgrade - Defense World
Keros Therapeutics (NASDAQ:KROS) Cut to “Hold” at Zacks Research - Defense World
(KROS) Risk Channels and Responsive Allocation - Stock Traders Daily
Keros Therapeutics (NASDAQ:KROS) Downgraded to Hold Rating by Zacks Research - MarketBeat
Keros Therapeutics (NASDAQ:KROS) Stock Price Down 3.3%Time to Sell? - MarketBeat
Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics - Yahoo Finance
Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Drops By 16.6% - MarketBeat
5 Low Price-to-Book Stocks to Buy as 2025 Comes to a Close - Yahoo Finance
KROS or ARGX: Which Is the Better Value Stock Right Now? - sharewise.com
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):